Establishment of the appropriate dose constraints of the critical organs in the combination of brachytherapy and intensity-modulated radiation therapy for prostate cancer
| Project/Area Number |
24791284
|
|---|
| Research Category |
Grant-in-Aid for Young Scientists (B)
|
| Allocation Type | Multi-year Fund |
|---|
| Research Field |
Radiation science
|
|---|
| Research Institution | Kanazawa University |
|---|
Principal Investigator |
|
|---|
| Research Collaborator |
TAKANAKA Tsuyoshi
TAKAMATSU Shigeyuki
MIZUNO Ei-ichi
SHIBATA Satoshi
FUJITA Shinji
MIZUHATA Miyu
NAMIKI Mikio
MIZOKAMI Atsushi
KONAKA Hiroyuki
KITAGAWA Yasuhide
KURATA Yu-ichi
UEDA Shin-ichi
|
|---|
| Project Period (FY) |
2012-04-01 – 2016-03-31
|
| Project Status |
Completed (Fiscal Year 2015)
|
| Budget Amount *help |
¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
Fiscal Year 2015: ¥130,000 (Direct Cost: ¥100,000、Indirect Cost: ¥30,000)
Fiscal Year 2014: ¥130,000 (Direct Cost: ¥100,000、Indirect Cost: ¥30,000)
Fiscal Year 2013: ¥520,000 (Direct Cost: ¥400,000、Indirect Cost: ¥120,000)
Fiscal Year 2012: ¥650,000 (Direct Cost: ¥500,000、Indirect Cost: ¥150,000)
|
|---|
| Keywords | 放射線治療 / 小線源治療 / 強度変調放射線治療 / 前立腺癌 |
|---|
| Outline of Final Research Achievements |
The purpose of the study was to clarify the appropriate dose constraints of the critical organs in the combination of brachytherapy and intensity-modulated radiation therapy for intermediate/high risk prostate cancer. We examined the dose of each critical organ in the treatment planning of both treatment and the frequency of the adverse events. We showed that this combination therapy was safe without serious adverse event if satisfying the proposed dose constraints for the critical organ (urethra, rectum, bladder and bowel) in each of brachytherapy and IMRT.
|
Report
(5 results)
Research Products
(7 results)
